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Background: Several studies have reported that carotid endarterectomy with patch angioplasty is superior to primary
closure. Conventional polytetrafluoroethylene (Gore-Tex, W. L. Gore & Associates, Flagstaff, Ariz) patching has been
shown to have results similar to autogenous saphenous vein patching; however, it requires a longer hemostasis time. This
study examined the long-term clinical outcome and incidence of restenosis after carotid endarterectomy using the new
ACUSEAL (Gore-Tex) patching vs Hemashield Finesse (Boston Scientific Corp, Natick, Mass) patching.
Methods: The study randomized 200 patients (1:1) undergoing carotid endarterectomy to 100 with ACUSEAL patching
and 100 with Hemashield-Finesse patching. All patients underwent immediate and 1-month postoperative duplex
ultrasound studies, which were repeated at 6-month intervals. Kaplan-Meier analysis was used to estimate the freedom
from stroke, stroke-free survival, and the risk of restenosis for both groups.
Results: The demographic and clinical characteristics, the mean operative diameter of the internal carotid artery, and the
length of the arteriotomy were similar in both groups. The mean hemostasis time was 5.1 for the ACUSEAL patching vs
3.7 minutes for Finesse patching (P  .01); however, the mean operative times were similar for both groups (P  .61).
The incidence of ipsilateral stroke was 2% for ACUSEAL patching (both early perioperative strokes) vs 3% for Finesse
patching (2 early and 1 late stroke) at a mean follow-up of 21 months. The respective cumulative stroke-free rates at 1,
2, and 3 years were 98%, 98%, and 98% for ACUSEAL patching vs 97%, 97%, and 97% for Finesse patching (P .7). The
respective cumulative stroke-free survival rates at 1, 2, and 3 years were 97%, 92%, and 88% for ACUSEAL patching vs
96%, 96%, and 91% for Finesse patching (P .6). The respective freedom from>70% carotid restenosis at 1, 2, and 3 years
was 98%, 96%, and 89% for ACUSEAL patching vs 92%, 85%, and 79% for Finesse patching (P  .04).
Conclusions: Carotid endarterectomy with ACUSEAL patching and Finesse patching had similar stroke-free rates and
stroke-free survival rates. The mean hemostasis time for the ACUSEAL patch was 1.4 minutes longer than that for the
Finesse patch; however, the Finesse patch had higher restenosis rates than the ACUSEAL patch. (J Vasc Surg 2008;48:
99-103.)Carotid endarterectomy (CEA) with patch angioplasty
has been shown by multiple clinical trials to be more
effective than CEA with primary closure in decreasing the
incidence of perioperative stroke, perioperative carotid
thrombosis, and late restenosis.1-7 The ideal carotid patch
has yet to be identified. Proponents of synthetic patches
and of autogenous vein patches have yet to reach a consen-
sus on the optimal patch material.1-7
Several studies have shown comparable results using
autogenous vein patching and polytetrafluoroethylene
(PTFE) patching,2,3,5,8,9 and also between autogenous
vein patching and Dacron patching.2,10-12 Several advan-
tages of synthetic patches compared with vein patches have
been cited, including decreased operative times, decreased
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doi:10.1016/j.jvs.2008.01.057incidence of aneurysmal dilatation or patch rupture, avail-
ability, and avoiding harvest site complications. Few stud-
ies, however, have demonstrated a prolonged hemostasis
time when using PTFE patches.5,8,13,14 Because of this
concern, W. L. Gore & Associates Inc (Flagstaff, AZ)
introduced a newmodified PTFE patch (ACUSEAL) in the
last few years, which it claims has a better hemostasis time
than conventional PTFE patching.
We previously reported results from a prospective study
using the ACUSEAL patch, showing bleeding times similar
to historic results (3 minutes) of the Dacron patch.15
Meanwhile, within the last few years, a new collagen-
impregnated Dacron patch was released, Finesse (Boston
Scientific Corp, Natick,Mass), that was designed to limit its
thrombogenicity. We reported previously on the early re-
sults from the prospective randomized trial that compared
these two commercially available patches used during
CEA.16 The purpose of this study is to report on the late
follow-up of both of these patches.
Patient population and methods. This study ran-
domly assigned 200 patients undergoing CEA to arteriot-
omy closure with the ACUSEAL PTFE patch or with the
Finesse collagen-impregnated Dacron patch. The Gore-
Tex ACUSEAL cardiovascular patch uses advanced flu-
oropolymer technology enabling it to “seal” around pene-
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as 88%. This, combined with improved suture retention
and multidirectional strength, sets the patch apart from
other PTFE patches. Increased sealing of suture holes to
minimize bleeding is achieved by including a middle layer
of a proprietary thermoplastic fluoropolymer with elastic
properties. The addition of the dense middle layer actually
increases the suture retention by approximately 10%. The
Finesse patch is an ultrathin knitted polyester fabric that is
impregnated with highly purified collagen, which is present
on both sides of the patch, to minimize bleeding.
This study was conducted between August 2003 and
October 2005 and was approved by the Institutional Re-
view Board of Charleston Area Medical Center, Robert C.
Byrd Health Sciences Center of West Virginia University.
Patients undergoing CEA with concomitant coronary ar-
tery bypass grafting, re-do CEAs, and patients with high
cervical lesions and severely elongated (kinked) arteries
were excluded from this study.
All patients underwent color carotid duplex ultrasound
(DUS) imaging or magnetic resonance angiography, or
both, to determine preoperative stenosis. All demographic
and clinical characteristics were recorded.
Randomization in a 1:1 ratio was accomplished by
using sealed opaque envelopes, each containing a slip of
paper with the patient’s patch assignment. Details of the
randomization and the operative techniques have been
described previously.16 In summary, all ACUSEAL
PTFE patches and Finesse Hemashield patches were
sutured using 6-0 Prolene suture (Ethicon, Summerville,
NJ). Dextran-40 was given intravenously (25 mL/h) at
the time of the CEA and continued for 24 hours.
After completion of patching and release of the carotid
clamps, if no suture bleeding points were noted, the hemo-
stasis time was recorded as zero. If bleeding points were
noted, thrombin-soaked oxidized cellulose and digital
pressure were applied to stop any bleeding points before
closure. Hemostasis was checked after 3 minutes, and if
necessary, in 2-minute intervals. Time required for repair
stitches, such as for localized poor opposition of the arterial
wall and patches, was excluded. All patients were started on
an aspirin regimen (325 mg daily) 24 hours of their
surgery, and this was continued indefinitely.
Surveillance protocol. Immediate postoperative DUS
scans, done in the operating room, if scanning equip-
ment and technician were available, otherwise 24
hours, were obtained using an ATL HDI-5000 system
(Advanced Technology Laboratory, Phillips, Bellevue,
Wash). All patients underwent clinical observation and
an examination by another surgeon who was blinded to
the type of patch. All patients underwent repeat carotid
DUS studies at 30 days, which was repeated at 6 months
and every 6 months thereafter. Carotid restenosis of
70% was defined by a peak systolic velocity of 150
cm/s on DUS examination with spectral broadening
through systole and an end-diastolic velocity of 90
cm/s.17Transient ischemic attack (TIA) was defined as a tran-
sient neurologic deficit lasting 24 hours. A stroke was
defined as a neurologic deficit lasting 24 hours.
Statistical analysis. All statistical analyses were per-
formed using SAS software (SAS Inc, Cary, NC). Contin-
uous variables were compared using the two-tailed Student
t test for independent measures and are represented as
mean and standard deviation (SD). Morbidity rates and
other categoric variables were analyzed with 2 or Fisher
exact test. A value of P  .05 was considered statistically
significant. A Kaplan-Meier analysis was used to estimate
the freedom from stroke, stroke-free survival, and the risk
of restenosis for both groups.
RESULTS
As indicated in our previous study,16 the differences in
demographic and clinical characteristics in both groups
were not statistically significant. The mean operative diam-
eter of the internal carotid artery and the length of the
arteriotomy were also similar in both groups.16 The mean
(SD) hemostasis time for the ACUSEAL patch was 5.17
(5.2) minutes, with a median of 4 minutes (range, 0-35
minutes) vs a mean of 3.7 (2.7) minutes for the Finesse
patch (range, 0-15 minutes; P  .01). The mean operative
times were similar for both groups (P  .61). The mean
follow-up of 21 months was also similar in both groups.
The perioperative morbidity and mortality were compara-
ble and have been reported previously.16
The incidence of ipsilateral stroke was 2% for the
ACUSEAL patch (both early perioperative strokes) vs 3% for
the Finesse patch (2 early perioperative strokes, 1 late stroke
associated with 70% restenosis) at a mean follow-up of 21
months. The combined (early and late) TIA and stroke and
asymptomatic 70% restenosis rate was 7% for ACUSEAL
patching vs 17% for the Finesse patching (P .048).
Table I summarizes the overall TIA, ipsilateral stroke,
morbidity, and mortality rate according to the type of
patch. Two patients with ACUSEAL patching sustained
Table. Overall morbidity and mortality by patch type
ACUSEAL,
No.
Finesse,
No. Pa
CEA 100 100 ...
Ipsilateral strokes (early and late) 2 3 .99
Early stroke 2 2
Late stroke 0 1
All ipsilateral TIAs (early and late) 3 6 .498
Early TIA 0 2
Late TIA 3 4
All TIAs and strokes 5 9 .407
All-cause mortality 6 3 .498
Stroke mortality 1 0
All TIA, stroke or death 10 12 .822
70% restenosis 4 12b .07
CEA, Carotid endarterectomy; TIA, Transient ischemic attack.
aBy Fisher exact test or 2, where appropriate.
bThis includes 2 carotid occlusions.perioperative ipsilateral strokes. One patient had a normal
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patient had a neurologic deficit in the operating room and
underwent an immediate intraoperative angiogram, fol-
lowed by exploration with thrombectomy to remove what
was thought to be white clots (with no carotid occlusion),
and was re-patched. The patient recovered from her stroke
1 week and had a normal DUS study result at 30 days.
Two patients with Finesse patching had minor peri-
operative ipsilateral strokes with normal postoperative
carotid DUS studies, and one patient had a late stroke,
which was associated with70% restenosis. Three patients
with ACUSEAL patching had late TIAs; two were associ-
ated with 70% restenosis and were treated with carotid
artery stenting, and the third patient had no restenosis. In
contrast, six patients with Finesse patching had TIAs; two
were early perioperative TIAs with normal carotid DUS
scans, and four were late TIAs, three of which were associ-
ated with70% restenosis, which were treated with carotid
artery stenting, and one patient had no restenosis.
As noted in Fig 1, the rates of freedom from stroke
(ipsilateral) at 1, 2, and 3 years were, respectively, 98%,
98%, and 98% for ACUSEAL vs 97%, 97%, and 97% for
Finesse (the log-rank, P  .65). Fig 2 summarizes the
stroke-free survival rates for both patches. The ipsilateral
stroke-free survival rates at 1, 2, and 3 years were, respec-
tively, 97%, 92%, and 88% for ACUSEAL vs 96%, 96%, and
91% for Finesse (log-rank P  .60). Fig 3 summarizes the
rate of freedom from 70% restenosis at 1, 2, and 3 years,
which was, respectively, 98%, 96%, and 89% for ACUSEAL
vs 92%, 85%, and 79% for Finesse (log-rank P  .04).
Overall, four patients with ACUSEAL patching had
70% restenosis, two of whom were symptomatic (TIA) vs
12 patients with Finesse patching, four of whom were
symptomatic (3 late TIAs and 1 late stroke). Overall, four
patients with ACUSEAL patching had70% to 99% reste-
nosis and three underwent carotid artery stenting, com-
Fig 1. Kaplan-Meier analysis for freedom from stroke using
ACUSEAL (triangles) and Finesse patching (circles).pared with 10 patients with Finesse patching who had70% to 99% restenosis, of whom four underwent carotid
artery stenting and six were observed.
DISCUSSION
Several studies, including a recent systematic review of
randomized controlled trials, have confirmed that CEA
with patch angioplasty decreases perioperative stroke rates,
perioperative carotid thrombosis, and recurrent carotid
stenosis compared with primary repair.1-7,18 However, no
specific patch material has been shown to be superior.4,9
The prevention of early thrombosis with patch closure
occurs by changing flow characteristics and by widening the
Fig 2. Kaplan-Meier analysis for stroke-free survival using
ACUSEAL (triangles) and Finesse patching (circles).
Fig 3. Kaplan-Meier analysis for freedom from 70% restenosis
using ACUSEAL (triangles) and Finesse patching (circles).artery. Patching reduces the incidence of intimal hyperpla-
JOURNAL OF VASCULAR SURGERY
July 2008102 AbuRahma et alsia.19,20 Bond et al7 and Counsell et al9 performed a
systematic review of randomized carotid trials and con-
cluded that the results of synthetic and autogenous vein
patching were similar.9 Many authorities, however, prefer a
synthetic patch because it is readily available, eliminates
wound complications from vein harvest sites, reduces po-
tential patch ruptures or aneurysmal changes, and preserves
the autogenous vein for future coronary or peripheral re-
vascularizations.
One of the main criticisms of the conventional PTFE
patch is the hemostasis time.5,8,13,14 We previously dem-
onstrated a mean hemostasis time of 14 minutes for the
conventional PTFE patch and only 3 minutes for the new
ACUSEAL patch.15 Although the difference between the
5-minute hemostasis time for the ACUSEAL patch and the
3.7-minute hemostasis time for the Finesse patch was sta-
tistically significant, its clinical significance is debatable in
this present study.
The overall comparison of perioperative (30-day) ipsi-
lateral stroke or TIA events between the two patches did
not demonstrate any statistically significant differences. The
ACUSEAL patch had an overall neurologic event rate of 2%
(2 ipsilateral strokes), and the Finesse patch had a rate of 4%
(2 ipsilateral strokes; 2 TIAs).16
In contrast, the late results, with a mean follow-up time
of 21 months, showed some statistically significant out-
comes, particularly in restenosis rates. Similar results were
found between the patches for overall neurologic events
(TIA/ipsilateral strokes), but the combination of all neu-
rologic events with asymptomatic 70% restenosis rates
was statistically significantly better for the ACUSEAL patch
(P  .048).
The freedom from 70% restenosis events at 1, 2, and
3 years was, respectively, 98%, 96%, and 89% for ACUSEAL
patching vs 92%, 85%, and 79% for Finesse patching (P 
.04). Of the 12 patients in this category for the Finesse
patch, two had perioperative carotid occlusions in con-
trast to no carotid occlusions with the ACUSEAL patch.
It should be noted that our criteria for defining 70%
stenosis has been published previously,17 with a sensitiv-
ity of 85%, specificity of 95%, positive-predictive value of
91%, negative-predictive value of 92%, and an overall
accuracy of 92%. All patients with 70% restenosis ac-
cording to our criteria were also verified using the con-
sensus criteria for carotid stenosis that were published
previously (a peak systolic velocity of 230 cm/s).21
Overall, two of four ACUSEAL patients and four of
12 Finesse patients with 70% restenosis became symp-
tomatic. The ACUSEAL group included two TIAs,
whereas the Finesse group included three TIAs and one
ipsilateral stroke. All six symptomatic patients underwent
successful carotid artery stenting, as did one asymptom-
atic ACUSEAL patient.
The late results of the ACUSEAL PTFE patching in the
present study were similar to what we published previously
using the same patch.15 To our knowledge, no other stud-
ies have been reported using the ACUSEAL patch after
CEA. Meanwhile, the early and late results of the FinesseDacron patch in the present study were superior to our past
experience using the conventional Dacron Hemashield
patch, which had a higher perioperative carotid thrombosis
rate of 5% vs 2% in the present series.20 In a previously
published prospective randomized trial of CEA with pri-
mary closure vs patching using saphenous vein, jugular
vein, and PTFE patching, a multiple linear regression anal-
ysis showed that the incidence of 50% restenosis was
associated more strongly with primary closure and female
sex. However, no statistically significant differences in fe-
male sex was noted in our present study between
ACUSEAL patching and Finesse patching.5
To our knowledge, no data have been published
using Finesse Dacron patches after CEA. However,
Ricco et al22 analyzed the use of collagen-impregnated
knitted polyester patches (Hemacarotid patch, Ultra-
thin, Intervascular, W.L. Gore & Associates, Flagstaff,
Ariz) in 221 CEAs and reported a 1.8% ipsilateral occlu-
sion rate with a 1.4% ipsilateral stroke rate and a 1.4%
ipsilateral TIA rate. They also reported that the percent-
age of women free from a 50% restenosis was 82% at 3
years, compared with 90% for men for the same period
(P .035). Because of these results, they concluded that
the use of these patches should be restricted to men.
The data presented in this study raise the question of
whether this Hemashield patch is thrombogenic in the
carotid location. Collagen-impregnated Dacron has gained
wide acceptance as a conduit in aortic aneurysm repair and
in aortoiliac reconstruction since the mid-1980s. Implan-
tation of various grafts in dogs showed medium-porosity
knitted Dacron to have better endothelial coverage, peri-
graft attachment, and thrombus-free surface than collagen-
impregnated knitted Dacron.23 It is possible that the
bovine collagen found in collagen-impregnated knitted
Dacron grafts does not experience the “washout” of colla-
gen in the carotid artery as fast as it does in a large-diameter
high-flow conduit such as an aortic graft. Several authors
have shown in animal experimental models that Dacron
prostheses have different characteristics when placed in the
thoracic and abdominal aorta24 and in the carotid and
femoral sites.25 The environment of the endarterectomized
carotid artery is very different from that of the aorta, mainly
because of the presence of denuded adventitia with its
exposed collagen along the carotid bifurcation. Studies
have shown increased platelet deposition on both PTFE
and knitted Dacron, with a greater deposition on knitted
Dacron.26
CONCLUSION
Carotid endarterectomy with ACUSEAL patching
and Finesse patching had similar ipsilateral stroke and
stroke survival rates. The mean hemostasis time for the
ACCUSEAL patch was 1.4 minutes longer than that for
the Finesse patch; however, the Finesse patch had higher
restenosis rates than the ACCUSEAL patch.
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